Ruíz-Castellano, María
1271  results:
Search for persons X
?
4

Rivaroxaban versus warfarin to treat patients with thrombot..:

Cohen, Hannah ; Hunt, Beverley J ; Efthymiou, Maria...
Cohen , H , Hunt , B J , Efthymiou , M , Arachchillage , D R J , Mackie , I J , Clawson , S , Sylvestre , Y , Machin , S J , Bertolaccini , M L , Ruiz-Castellano , M , Muirhead , N , Doré , C J , Khamashta , M & Isenberg , D A 2016 , ' Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial ' , The Lancet Haematology , vol. 3 , no. 9 , pp. e426-e436 . https://doi.org/10.1016/S2352-3026(16)30079-5.  , 2016
 
?
6

Rivaroxaban versus warfarin to treat patients with thrombot..:

Cohen, Hannah ; Hunt, Beverley J ; Efthymiou, Maria...
Cohen , H , Hunt , B J , Efthymiou , M , Arachchillage , D R J , Mackie , I J , Clawson , S , Sylvestre , Y , Machin , S J , Bertolaccini , M L , Ruiz-Castellano , M , Muirhead , N , Doré , C J , Khamashta , M & Isenberg , D A 2016 , ' Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial ' , The Lancet Haematology , vol. 3 , no. 9 , pp. e426-e436 . https://doi.org/10.1016/S2352-3026(16)30079-5.  , 2016
 
1-15